These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26820850)

  • 1. Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications.
    Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Ouattara A; Takala-Harrison S; Berry AA; Doumbo OK; Plowe CV
    PLoS One; 2016; 11(1):e0148240. PubMed ID: 26820850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
    Chitnis CE; Mukherjee P; Mehta S; Yazdani SS; Dhawan S; Shakri AR; Bhardwaj R; Gupta PK; Hans D; Mazumdar S; Singh B; Kumar S; Pandey G; Parulekar V; Imbault N; Shivyogi P; Godbole G; Mohan K; Leroy O; Singh K; Chauhan VS
    PLoS One; 2015; 10(9):e0137816. PubMed ID: 26332825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria.
    Chaorattanakawee S; Nuchnoi P; Hananantachai H; Tumkosit U; Saunders D; Naka I; Ohashi J; Patarapotikul J
    PLoS One; 2018; 13(4):e0196694. PubMed ID: 29694418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Targeting of a Transporter to the Outer Apicoplast Membrane in the Human Malaria Parasite Plasmodium falciparum.
    PLOS ONE Staff
    PLoS One; 2016; 11(8):e0161420. PubMed ID: 27548067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Balancing selection and high genetic diversity of Plasmodium vivax circumsporozoite central region in parasites from Brazilian Amazon and Rio de Janeiro Atlantic Forest.
    Almeida-de-Oliveira NK; Abreu-Fernandes R; Lima-Cury L; Lavigne AR; Pina-Costa A; Perce-da-Silva DS; Catanho M; Rossi AD; Brasil P; Tadeu Daniel-Ribeiro C; Ferreira-da-Cruz MF
    PLoS One; 2022; 17(2):e0264054. PubMed ID: 35143581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro.
    Lithanatudom P; Wipasa J; Inti P; Chawansuntati K; Svasti S; Fucharoen S; Kangwanpong D; Kampuansai J
    PLoS One; 2016; 11(9):e0163430. PubMed ID: 27631391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
    Partey FD; Castberg FC; Sarbah EW; Silk SE; Awandare GA; Draper SJ; Opoku N; Kweku M; Ofori MF; Hviid L; Barfod L
    PLoS One; 2018; 13(9):e0204452. PubMed ID: 30222763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; MacDonald NJ; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
    PLoS One; 2016; 11(10):e0165489. PubMed ID: 27764243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Antimalarial drug resistance molecular markers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Hamid MMA; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2021; 16(1):e0245336. PubMed ID: 33406148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    Sedegah M; Peters B; Hollingdale MR; Ganeshan HD; Huang J; Farooq F; Belmonte MN; Belmonte AD; Limbach KJ; Diggs C; Soisson L; Chuang I; Villasante ED
    PLoS One; 2016; 11(12):e0168952. PubMed ID: 27997615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Identification of Plasmodium falciparum DNA Repair Protein Mre11 with an Evolutionarily Conserved Nuclease Function.
    Badugu SB; Nabi SA; Vaidyam P; Laskar S; Bhattacharyya S; Bhattacharyya MK
    PLoS One; 2023; 18(10):e0293936. PubMed ID: 37906581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana.
    Botwe AK; Owusu-Agyei S; Asghar M; Hammar U; Oppong FB; Gyaase S; Dosoo D; Jakpa G; Boamah E; Twumasi MF; Osier F; Färnert A; Asante KP
    PLoS One; 2021; 16(2):e0246773. PubMed ID: 33534827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Spatial variation in genetic diversity and natural selection on the thrombospondin-related adhesive protein locus of Plasmodium vivax (PvTRAP).
    Kosuwin R; Putaporntip C; Tachibana H; Jongwutiwes S
    PLoS One; 2018; 13(8):e0203163. PubMed ID: 30138471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.
    Silvino ACR; Costa GL; Araújo FCF; Ascher DB; Pires DEV; Fontes CJF; Carvalho LH; Brito CFA; Sousa TN
    PLoS One; 2018; 13(2):e0192534. PubMed ID: 29389962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana.
    Amoah LE; Asare KK; Dickson D; Abankwa J; Busayo A; Bredu D; Annan S; Asumah GA; Peprah NY; Asamoah A; Malm KL
    PLoS One; 2023; 18(11):e0294702. PubMed ID: 37967114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Correction: Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.
    PLOS ONE Staff
    PLoS One; 2016; 11(5):e0156011. PubMed ID: 27182809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
    Stoute JA; Slaoui M; Heppner DG; Momin P; Kester KE; Desmons P; Wellde BT; Garçon N; Krzych U; Marchand M
    N Engl J Med; 1997 Jan; 336(2):86-91. PubMed ID: 8988885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Imputation-Based Population Genetics Analysis of Plasmodium falciparum Malaria Parasites.
    PLOS Genetics Staff
    PLoS Genet; 2016 Aug; 12(8):e1006300. PubMed ID: 27579790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway.
    The
    PLoS One; 2015; 10(2):e0118160. PubMed ID: 25658426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.